LEPR and cancer: On the basis of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, the top three pathways distinguishing Lepr+ versus Lepr− basal SCC cells were small-cell lung cancer (oncogenic RAS-associated), pathways in cancer and the PI3K–AKT signalling pathway (Fig. 5b, top).